Transparency Market Research
(TMR) has published a new report titled, “Preterm Birth and PROM Testing -
Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.
According to the report, the global preterm birth
and PROM testing market was valued at US$ 150.5 Mn in
2017 and is anticipated expand at a CAGR of 8.0% from 2018 to 2026. Increase in
number of preterm births, growth of the medical diagnostics industry in
emerging economies in regions such as Asia Pacific, and adoption of latest
technologies and techniques to access or diagnose preterm births are projected
to augment the global market between 2018 and 2026.
Request a PDF Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=55416
Increase in Preterm Births to
Propel Market
Sedentary lifestyle along with several other factors has led to
increase in preterm births, which has become a major concern in the past few
years. According to the World Health Organization (WHO), nearly 15 million
babies are born early every year i.e., around 1 in every 10 babies is preterm.
Moreover, complications due to premature births result in fatal outcomes in
approximately 1 million cases. One of the major causes of such complications is
premature rupture of membranes (PROM), which accounts for roughly 30% of all
preterm births. The global preterm birth and PROM testing market is expected to
be driven by increase in incidence of such complications during the forecast
period.
Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=55416
Rise in Demand for Point-of-Care
Testing Devices to Present Significant Opportunities
Increase in demand for effective and early diagnosis and reduction
in false positive tests for diagnosis of premature births and PROM drive
adoption of point-of-care testing devices. Moreover, high adoption of these
devices can be attributed to reduced risk of misdiagnosis, ease of usage, and
high sensitivity. Point-of-care testing devices have also assisted in reducing
the chances of complications due to preterm births by enabling diagnosis at
early stages and allowing health care providers to offer immediate care to
mother and fetus at early stages of pregnancy.
Request for
Analysis of COVID19 Impact on Preterm Birth and PROM Testing Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=55416
Lack of Awareness about Preterm
Births to Restrain Market
Lack of awareness about preterm births and PROM could lead to
longer hospital stays and preventable expenditure from the perspective of
patients. Additionally, lack of awareness about availability of latest
technologies available for diagnosis of premature births, resulting in delayed
diagnosis and treatment is one of the major factors hampering the growth of the
market.
Asia Pacific Market to Grow at a
Rapid Pace
In terms of revenue, the preterm birth and PROM testing market in
Asia Pacific is projected to expand at a high CAGR during the forecast period.
Increase in awareness about the availability of point-of-care testing devices
and rise in technology penetration are expected to boost the demand for these
diagnostic techniques. Furthermore, surge in awareness about women’s health and
increase in expenditure on health care in the region are anticipated to present
lucrative opportunities in the market in the next few years.
Buy now
Preterm Birth and PROM Testing Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=55416<ype=S
Collaborative Efforts by Key
Players to Boost Market
The report also provides profiles of leading players operating in
the global preterm and PROM testing market. These include NX Prenatal, Inc., IQ
Products, QIAGEN, Hologic, Inc., The Cooper Companies, Inc., Medix Biochemica,
Abbott Laboratories, Clinical Innovations, LLC, Sera Prognostics, Inc., and
Biosynex. Launch of new products, focus on developing technologically advanced
products, and increase in mergers & acquisitions, expansion, and strategic
collaborations with companies and government organizations are expected to
drive the global market during the forecast period. In October 2018, Sera
Prognostics entered into collaboration with Laboratory Corporation of America
Holdings (LabCorp), a life sciences company, to be the exclusive U.S.
distributor of Sera’s PreTRM test. In the same month, NX Prenatal, Inc. entered
into a collaboration with the Indiana University School of Medicine to validate
its early pregnancy biomarker panels predicting spontaneous preterm birth
(SPTB) and to develop its biomarker panels for preeclampsia (PE).
More Trending Reports by
Transparency Market Research:
https://www.prnewswire.com/news-releases/global-customized-procedure-trays-market-to-grow-as-the-medical-industry-acquires-research-excellence-says-tmr-301210766.html
https://www.prnewswire.com/news-releases/technological-strides-in-bladder-scanners-market-help-clinicians-advance-care-for-patients-with-urinary-tract-infections-valuation-to-touch-mark-of-us-210-0-mn-by-2026-tmr-301213972.html
About Us
Transparency Market Research is a global market intelligence
company, providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis provides
forward-looking insight for thousands of decision makers. Our experienced team
of Analysts, Researchers, and Consultants, use proprietary data sources and
various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team
of research experts, so that it always reflects the latest trends and
information. With a broad research and analysis capability, Transparency Market
Research employs rigorous primary and secondary research techniques in
developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/
